This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should You Hold On to Teladoc Health (TDOC) Stock for Now?
by Zacks Equity Research
Teladoc Health's (TDOC) cash flows will likely gain from the growing number of visits and memberships.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $34.61 in the latest trading session, marking a +0.23% move from the prior day.
Which Pandemic Winners Are Still Worth Investors' Attention?
by Derek Lewis
While many stocks suffered from the pandemic's initial economic impact, a handful actually benefited.
Why Is Charles River (CRL) Down 1.2% Since Last Earnings Report?
by Zacks Equity Research
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) Down 0.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pandemic Winners Turned Losers: Should You Still Buy?
by Derek Lewis
Once prosperous investments throughout the pandemic, the high-flying days for these stocks is well over in 2022.
Teladoc (TDOC) Plunges 40.3% Since Q1 Earnings Beat: Here's Why
by Zacks Equity Research
Teladoc Health's (TDOC) bet on mental health service BetterHelp is likely to generate lower yield this year.
Making Sense of Tech Sector Earnings After a Big Week of Results
by Sheraz Mian
Total Q1 earnings for the 'Big 5 Tech' players are down -8.4% from the same period last year on +11.4% higher revenues, with a 421 basis-points (bps) compression in net margins
The Zacks Analyst Blog Highlights Antero Resources, Arthur J. Gallagher, Teladoc Health, W. P. Carey and Weyerhaeuser
by Zacks Equity Research
Antero Resources, Arthur J. Gallagher, Teladoc Health, W. P. Carey and Weyerhaeuser have been included in this Analyst Blog.
Teladoc (TDOC) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 14.55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks to Buy Ahead of Q1 Earnings Results This Week
by Nalak Das
Five companies with a favorable Zacks Rank will report first-quarter earnings results this week. These are: WPC, WY, TDOC, AR and AJG.
Teladoc (TDOC) Stock Moves -1.35%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $58.25, marking a -1.35% move from the previous day.
Teladoc (TDOC) Eyes Q1 Earnings Beat on Rising US Paid Members
by Zacks Equity Research
Teladoc Health's (TDOC) first-quarter 2022 results are likely to reflect improved subscription access fees revenues.
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Stock Moves -0.38%: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $65.81 in the latest trading session, marking a -0.38% move from the prior day.
Teladoc (TDOC) Stock Moves -1.29%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $72.13, marking a -1.29% move from the previous day.
Why You Should Retain Teladoc Health (TDOC) Stock for Now
by Zacks Equity Research
Teladoc Health (TDOC) is focused on making strategic partnerships to boost user numbers.
Teladoc (TDOC) Up 12.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) Stock Moves -0.94%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $69.22, marking a -0.94% move from the previous day.
Teladoc Health's (TDOC) Virtual Care Model to Aid Companies
by Zacks Equity Research
Teladoc Health's (TDOC) first industry-standard model to help employers improve their package of telehealth services.
Teladoc (TDOC) Stock Moves -0.24%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $63.55, marking a -0.24% move from the previous day.
Teladoc Health (TDOC) Tumbling: Is it Healthy for Your Portfolio?
by Zacks Equity Research
For this year, Teladoc Health (TDOC) projects total visits in the band of 18.5-20 million, indicating a rise from the 2021 level of 15.4 million.
Stock Market News for Mar 1, 2022
by Zacks Equity Research
U.S. stocks market closed mixed on Monday, the last trading day of February.
Teladoc Health (TDOC), Amazon Tie Up to Advance Virtual Care
by Zacks Equity Research
Teladoc Health (TDOC) collaborates with Amazon so that customers can avail quick and effective virtual care medical services via their Alexa-activated intelligent speakers.
Teladoc (TDOC) Q4 Loss Narrows on Higher Visits, Memberships
by Zacks Equity Research
Teladoc (TDOC) projects 2022 total visits in the band of 18.5-20 million, indicating an uptick from the 2021 level of 15.4 million.